January 2022 – MolGenie

Anixa-MolGenie compounds are more potent than the protease inhibitor in Pfizer’s PAXLOVID™ at inhibiting the main protease of SARS-CoV-2

SAN JOSE, Calif. and STUTTGART, Germany, Jan. 24, 2022 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused […]